Skip to main content
Terug
Watch Compare

Passage BIO, Inc.

Datakwaliteit: 83%
PASG
Nasdaq Manufacturing Chemicals
€ 9,89
▼ € 1,30 (-11,62%)
Marktkapitalisatie: 35,74 M
Prijs
€ 11,14
Marktkapitalisatie
35,74 M
Dagbereik
—
52-Weeksbereik
—
Volume
—
Openen —
50D / 200D Gem.
—
50D / 200D Gem.
—

Quick Summary

Belangrijkste Punten

Negative free cash flow of -31,51 M

Groei

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
-131,23%
Onder sectorgemiddelde (-53,53%)
ROIC-69,97%
Net MarginN/A
Op. MarginN/A

Veiligheid

Debt / Equity
N/A
Current Ratio2,51
Interest CoverageN/A

Waardering

PE (TTM)
-0,79
Boven sectorgemiddelde (-1,48)
P/B Ratio1,15
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Manufacturing sector mediaan (1366 peers)
Metriek Aandeel Sector Mediaan
P/E -0,8 -1,5
P/B 1,2 1,6
ROE % -131,2 -53,5
Net Margin % — -41,5
Rev Growth 5Y % — 1,8
D/E — 0,3

Koersdoel Analisten

6 analisten
Buy
Huidig
€ 9,89
+210.1%
Koersdoel
€ 30,67
€ 10,00
€ 26,50
€ 68,00
Vooruitzicht
Forward K/W -1,12
Forward WPA -€ 8,80
Omzet Sch. 0,0

Winstschattingen

Periode WPA Sch. Omzet Sch. Analisten
FY2027 -€ 8,80
-€ 19,12 – -€ 2,26
 0,0 4
FY2026 -€ 8,91
-€ 14,23 – -€ 3,03
 0,0 6

Winstverassingen

Laatste 4 kwartalen
Kwartaal Geschat WPA Werkelijk WPA Verrassing
Q42025 -€ 2,80 -€ 4,09 -46,3%
Q32025 -€ 2,97 -€ 2,44 +17,9%
Q22025 -€ 4,15 -€ 2,96 +28,7%
Q12025 -€ 4,47 -€ 5,00 -11,9%

ETFs Holding This Stock

BRSIX BRSIX
0,03% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -45,52 M
ROE -131,23% ROA -59,37%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -31,51 M
ROIC -69,97% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 2,51
Interest Coverage N/A Asset Turnover N/A
Working Capital 33,49 M Tangible Book Value 31,12 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0,79 Forward P/E N/A
P/B Ratio 1,15 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -88,17%
Market Cap 35,74 M Enterprise Value -17,04 M
Per Share
EPS (Diluted TTM) -14,35 Revenue / Share N/A
FCF / Share -9,82 OCF / Share -9,82
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 69,22%
SBC-Adj. FCF -35,30 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — — —
Net Income -45,52 M -64,77 M -102,06 M -136,13 M -185,39 M
EPS (Diluted) -14,35 -1,07 -1,86 -2,50 -3,48
Gross Profit — — — — —
Operating Income -49,30 M -70,40 M -108,39 M -138,39 M -185,73 M
EBITDA — — — — —
R&D Expenses 23,28 M 40,18 M — — —
SG&A Expenses — — — — —
D&A 728.000,0 3,08 M 3,72 M 3,68 M 1,54 M
Interest Expense — — — — —
Income Tax 0,0 — — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 62,28 M 102,41 M 150,55 M 243,55 M 355,08 M
Total Liabilities 43,53 M 41,15 M 39,26 M 42,18 M 36,42 M
Shareholders' Equity 18,76 M 61,26 M 111,28 M 201,37 M 318,66 M
Total Debt — — — — —
Cash & Equivalents 46,30 M 37,57 M 21,71 M 34,60 M 128,97 M
Current Assets 47,76 M 78,82 M 117,96 M 197,04 M 325,07 M
Current Liabilities 23,08 M 19,36 M 16,34 M 18,35 M 29,50 M